 |
 |
I received the following message from Centerwatch, a clinical trials listing service. I thought some of the writers on our list might be interested in submiting articles for their new publication. You can find more information about Centerwatch, and sign up for their e-mail notification service on their homepage, http://www.CenterWatch.com/ The notification service is free, but I think they do charge for subscriptions to their publication. Linda Herman [log in to unmask] ----------------------------------------------------------------- Date: Wed, 19 Nov 1997 15:30:12 -0500 (EST) From: [log in to unmask] Message-ID: <[log in to unmask]> To: [log in to unmask] Subject: New CenterWatch Newsletter Editorial Contributions for New CenterWatch Newsletter In January, CenterWatch will launch New Medical Therapies, a new monthly newsletter for patients interested in clinical trials. I=92m writing today to solicit first-person articles from patients for the first few issues. New Medical Therapies will be the fourth newsletter published by CenterWatch, and the first geared toward patients. (Our other publications are read by researchers and sponsors of drug trials.) It will include: Reports on new drugs being tested and how the experimental drugs compare with existing therapies. Reviews of newly approved drugs. Updates on new trials being launched. Trial results of experimental drugs. Results of clinical tests of alternative therapies. In addition, New Medical Therapies is designed to serve as a forum for patients. We will be publishing articles about patients' rights in clinical trials, historical information relating to human subjects in clinical trials, etc. Most important, we want to make New Medical Therapies a newsletter that gives patients in clinical trials a voice. In each issue, we intend to include a first-person by-lined article from someone who has been in a clinical trial, describing first-hand his or her experience. The article will include an overview of the ailment, why the person volunteered, what the experience was like (pros and cons, etc.), and advice for others considering volunteering for a trial. We hope this feature will foster a sense of community among New Medical Therapies=92 readers, offering them the opportunity to learn from each other. The first-person articles will run from 700 to 1400 words in length. If you, or someone you know, is interested in submitting an article, please reply by e-mail to CenterWatch. ([log in to unmask]). I'll send you the guidelines for writing the piece. Our first issue of New Medical Therapies is scheduled for January 1998. If you are interested in submitting an article for the first issue, please contact me before December 5, 1997. Thank you! Joanna White New Medical Therapies Managing Editor